These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 4057576

  • 21. [The prognostic significance of determining androgen receptors in prostatic cancer].
    Kushlinskiĭ NE, Bassalyk LS, Svetozarskiĭ NL, Matveev BP, Gorilovskiĭ LM, Makarova GV, Bukharkin BV, Shakhov EV, Kliuchikhin OZ.
    Urol Nefrol (Mosk); 1993; (1):7-10. PubMed ID: 7941132
    [Abstract] [Full Text] [Related]

  • 22. Cancer of the prostate.
    N Engl J Med; 1968 Apr 11; 278(15):848-9. PubMed ID: 5642506
    [No Abstract] [Full Text] [Related]

  • 23. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F, Dupont A, Belanger A, Lefebvre FA, Raynaud JP.
    J Pharmacol; 1983 Apr 11; 14 Suppl 3():117-35. PubMed ID: 6423907
    [Abstract] [Full Text] [Related]

  • 24. Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.
    Nishiyama T, Suzuki K, Yamana K, Tonegawa E, Wako K, Takahashi K.
    Expert Rev Anticancer Ther; 2006 Feb 11; 6(2):259-68. PubMed ID: 16445378
    [Abstract] [Full Text] [Related]

  • 25. [Prostate cancer patients with lymph node metastasis. Outcome in a consecutive group of 59 patients].
    Røder MA, Reinhardt S, Brasso K, Iversen P.
    Ugeskr Laeger; 2008 Aug 18; 170(34):2554-8. PubMed ID: 18761838
    [Abstract] [Full Text] [Related]

  • 26. [Cancer of the prostate: subcapsular orchiectomy].
    Cukier J, Rivain T.
    Bull Cancer; 1985 Aug 18; 72(6):543-8. PubMed ID: 4092105
    [Abstract] [Full Text] [Related]

  • 27. Endocrine treatment of cancer of the prostate.
    Madsen PO, Pedersen JF, Knuth OE.
    Wis Med J; 1970 Jul 18; 69(7):177-81. PubMed ID: 4916084
    [No Abstract] [Full Text] [Related]

  • 28. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
    Morote J, Orsola A, Planas J, Trilla E, Raventós CX, Cecchini L, Catalán R.
    J Urol; 2007 Oct 18; 178(4 Pt 1):1290-5. PubMed ID: 17698136
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma.
    Takeda H, Akakura K, Masai M, Akimoto S, Yatani R, Shimazaki J.
    Cancer; 1996 Mar 01; 77(5):934-40. PubMed ID: 8608487
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
    Rogers C.
    J Urol; 2003 Nov 01; 170(5):1955; author reply 1955-6. PubMed ID: 14575038
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combined androgen blockade revisited: emerging options for the treatment of castration-resistant prostate cancer.
    Simmons MN, Klein EA.
    Urology; 2009 Apr 01; 73(4):697-705. PubMed ID: 19185908
    [No Abstract] [Full Text] [Related]

  • 40. Endocrine therapy for prostate cancer.
    Damber JE.
    Acta Oncol; 2005 Apr 01; 44(6):605-9. PubMed ID: 16165920
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.